ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)

ClinicalTrials.gov ID: NCT05879614

Public ClinicalTrials.gov record NCT05879614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 10:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001)

Study identification

NCT ID
NCT05879614
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Neuren Pharmaceuticals Limited
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • NNZ-2591 Drug

Drug

Eligibility (public fields only)

Age range
4 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2023
Primary completion
Jun 29, 2025
Completion
Jun 29, 2025
Last update posted
Dec 8, 2024

2023 – 2025

United States locations

U.S. sites
4
U.S. states
4
U.S. cities
4
Facility City State ZIP Site status
Rady Children's Hospital San Diego San Diego California 92123
Rare Disease Research Atlanta Georgia 30329
Uncommon Cures Chevy Chase Maryland 20815
Suburban Research Media Pennsylvania 19063

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05879614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 8, 2024 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05879614 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →